Orbimed Advisors LLC Ptc Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $48.9 Million - $63.2 Million	-1,148,723 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $18.8 Million - $34.5 Million	-580,477 Reduced 33.57%	1,148,723 $51.2 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $7.4 Million - $11.5 Million	-229,700 Reduced 11.73%	1,729,200 $83.1 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $4.42 Million - $6.3 Million	-130,800 Reduced 6.26%	1,958,900 $66.3 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $20.2 Million - $25.7 Million	570,000 Added 37.51%	2,089,700 $94 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $7.3 Million - $11.4 Million	244,700 Added 19.19%	1,519,700 $52.2 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $43.2 Million - $60.9 Million	1,275,000 New	1,275,000 $59.9 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.